UNSPSC 51283500: Penicillinase-resistant penicillins

This classification denotes highly-target-specific, second-generation penicillins chiefly employed against staphylococcal infections, especially against Staphylococcus aureus, and which are not rendered inactive by penicillinas, a beta-lactamase or bacteria-produced enzyme preferentially cleaving penicillins.

UNSPSC 51283500 Penicillinase-resistant penicillins is a Class code that in practice covers a much broader range of pharmaceutical and medical supply procurement than the code name suggests. Recent state and local solicitations under this code include naloxone and drug deactivation systems for county health departments, generic multi-source pharmaceuticals and OTC products through cooperative purchasing alliances, medical and first aid supplies for fire and rescue operations, and direct-to-manufacturer prescription programs. Issuing bodies span county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and state-led cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The mix reflects both individual jurisdictional procurements and coordinated regional or statewide cooperative purchasing vehicles for pharmaceutical and medical supply distribution.

Geographic activity centers on Florida, Texas, Minnesota, and Oregon, with additional participation in MMCAP's multi-state footprint. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies including respiratory equipment and cardiac monitoring electrodes with an estimated contract amount of $700,000, and Minnesota's MMCAP RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers effective July 1, 2026. The Tampa procurement is sheltered as a certified Small Local Business Enterprise set-aside with a 5 percent bid discount capped at $10,000. Texas HHS's RFI HHS0017013 (posted April 3, 2026) represents preliminary market intelligence gathering for a direct-to-manufacturer prescription program, signaling future formal procurement activity.